I-Rivaroxaban CAS: 366789-02-8 uMboneleli woMvelisi

I-Rivaroxaban i-agent ye-antithrombotic inoveli.Yinoveli, ngomlomo, inhibitor ekhethiweyo ethe ngqo ye-factor Xa ephuhliswe yi-Bayer Healthcare.Ivunyiwe yi-EMEA kunye ne-FDA yokuthintela i-thromboembolism eyingozi kwizigulane zabantu abadala emva kokutshintshwa kwe-hip epheleleyo okanye utyando olupheleleyo lokuguqa.

Iodolo okanye Cela iQuote

Iinkcukacha zeMveliso

Iithegi zeMveliso

Isicelo kunye nesiphumo

I-Rivaroxaban ineempawu eziphezulu ze-bioavailability, uluhlu olubanzi lwezifo ezijoliswe kuyo, ubudlelwane obuzinzile be-dose-effect, ukungenisa okulula komlomo, kunye nomngcipheko ophantsi wokuphuma kwegazi.I-Rivaroxaban inokuthintela nokuphatha i-thrombosis ye-venous.Isetyenziswa ikakhulu eklinikhi ukunqanda i-thrombosis enzulu ye-venous (DVT) kunye ne-pulmonary embolism (PE) kwizigulane zabantu abadala ezilandela utyando lokutshintshwa kwe-hip kunye nedolo.Ikwasetyenziselwa ukuthintela izigulane ezine-nonvalvular atrial fibrillation ezivela kwi-cerebral apoplexy kunye ne-noncentral nervous system embolism, kwaye inokunciphisa umngcipheko wokuphindaphinda kwe-coronary syndromes.

Isampulu yeMveliso

Ukupakishwa kweMveliso:

Iinkcukacha ezongezelelweyo:

Ukuqamba	I-C19H18ClN3O5S
Isivavanyi	99%
Imbonakalo	Umgubo omhlophe
Inombolo yeCAS.	366789-02-8
Ukupakisha	25KG
Beka ubomi kwishelufa	iminyaka eyi-2
Ugcino	Gcina kwindawo epholileyo neyomileyo
Isiqinisekiso	ISO.